We have examined the literature to identify genes most frequently hypermethylated in NSCLC, which led us to the investigation of the genes HOXA9 and SOX1 that have shown potential as diagnostic and prognostic biomarkers in NSCLC [11,12]. This evidence concerns the gene SOX1 and non-small cell lung carcinoma.